Severe persistent visual field constriction associated with vigabatrin

asymptomatic as well as symptomatic defects occur with vigabatrin

R. Mackenzie*, A. Klistorner

*Corresponding author for this work

Research output: Contribution to journalComment/opinion

48 Citations (Scopus)

Abstract

Editor—Since Eke et al's report of sympto­matic visual field defects in three patients taking vigabatrin, a drug surveillance database at Hoechst Marion Roussel had identified another 92 cases by June 1997. Asymptomatic visual field defects may be
more common, but the exact incidence is unknown and data on the results of field
testing and electrophysiology are lacking in this group. We report these results in two asymptomatic patients.
Original languageEnglish
Pages (from-to)233
Number of pages1
JournalBMJ (Clinical research ed.)
Volume316
Issue number7126
Publication statusPublished - 1998

    Fingerprint

Cite this